Canlyniadau Chwilio - Xia, Ruixiang

Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia gan Liang, Xinglin, Xia, Ruixiang

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib gan Chen, Xiaowen, Huang, Zhenqi, Wu, Wei, Xia, Ruixiang

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Application of High-Efficiency Cell Expansion and High-Throughput Drug Sensitivity Screening for Leukemia Treatment gan Li, Lili, Wang, Wenliang, Liang, Li, Ge, Jian, Xia, Ruixiang

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Functional role of regulatory T cells in B cell lymphoma and related mechanisms gan Wu, Wei, Wan, Jun, Xia, Ruixiang, Huang, Zhenqi, Ni, Jing, Yang, Mingzhen

Cael y testun llawn Cael y testun llawn

miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway gan Xia, Liang, Wu, Linlin, Xia, Hailong, Bao, Jing, Li, Qingsheng, Chen, Xiaowen, Xia, Ruixiang

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Long Non-coding RNA X-Inactive Specific Transcript Mediates Cell Proliferation and Intrusion by Modulating the miR-497/Bcl-w Axis in Extranodal Natural Killer/T-cell Lymphoma gan Liu, Qinhua, Ran, Ruonan, Wu, Zhengsheng, Li, Xiaodan, Zeng, Qingshu, Xia, Ruixiang, Wang, Yalei

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatm... gan Li, Qingsheng, Zhang, Linjie, Xia, Ruixiang, Zeng, Qingshu, Wang, Yongqing, Xia, Liang, Xia, Leiming, Yang, Mingzhen

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19 gan Luan, Chengxin, Wang, Haixia, Zhou, Junjie, Ma, Xiaoyu, Long, Zhangbiao, Cheng, Xin, Chen, Xiaowen, Xia, Ruixiang, Ge, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Case Report: Local Cytokine Release Syndrome in an Acute Lymphoblastic Leukemia Patient After Treatment With Chimeric Antigen Receptor T-Cell Therapy: A Possible Model, Literature... gan Luan, Chengxin, Zhou, Junjie, Wang, Haixia, Ma, Xiaoyu, Long, Zhangbiao, Cheng, Xin, Chen, Xiaowen, Huang, Zhenqi, Zhang, Dagan, Xia, Ruixiang, Ge, Jian

Cael y testun llawn Cael y testun llawn Cael y testun llawn

TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes gan Hong, Jian, Xia, Leiming, Huang, Zhenqi, Yuan, Xiaodong, Liang, Xinglin, Dai, Jifei, Wu, Zhonghui, Liang, Li, Ruan, Min, Long, Zhangbiao, Cheng, Xin, Chen, Xiaowen, Ni, Jing, Ge, Jian, Li, Qingsheng, Zeng, Qingshu, Xia, Ruixiang, Wang, Yi, Yang, Mingzhen

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy gan Yang, Mingya, Wang, Lei, Ni, Ming, Neuber, Brigitte, Wang, Sanmei, Gong, Wenjie, Sauer, Tim, Schubert, Maria-Luisa, Hückelhoven-Krauss, Angela, Xia, Ruixiang, Ge, Jian, Kleist, Christian, Eckstein, Volker, Sellner, Leopold, Müller-Tidow, Carsten, Dreger, Peter, Schmitt, Michael, Schmitt, Anita

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Selectively targeting FLT3-ITD mutants over FLT3- wt by a novel inhibitor for acute myeloid leukemia gan Wang, Aoli, Hu, Chen, Chen, Cheng, Liang, Xiaofei, Wang, Beilei, Zou, Fengming, Yu, Kailin, Li, Feng, Liu, Qingwang, Qi, Ziping, Wang, Junjie, Wang, Wenliang, Wang, Li, Weisberg, Ellen L., Wang, Wenchao, Li, Lili, Ge, Jian, Xia, Ruixiang, Liu, Jing, Liu, Qingsong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia... gan Wu, Jiaxin, Wang, Aoli, Li, Xixiang, Chen, Cheng, Qi, Ziping, Hu, Chen, Wang, Wenliang, Wu, Hong, Huang, Tao, Zhao, Ming, Wang, Wenchao, Hu, Zhenquan, Liu, Qingwang, Wang, Beilei, Wang, Li, Li, Lili, Ge, Jian, Ren, Tao, Xia, Ruixiang, Liu, Jing, Liu, Qingsong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia gan Mei, Heng, Liu, Xiaofan, Li, Yan, Zhou, Hu, Feng, Ying, Gao, Guangxun, Cheng, Peng, Huang, Ruibin, Yang, Linhua, Hu, Jianda, Hou, Ming, Yao, Yazhou, Liu, Li, Wang, Yi, Wu, Depei, Zhang, Liansheng, Zheng, Changcheng, Shen, Xuliang, Hu, Qi, Liu, Jing, Jin, Jie, Luo, Jianmin, Zeng, Yun, Gao, Sujun, Zhang, Xiaohui, Zhou, Xin, Shi, Qingzhi, Xia, Ruixiang, Xie, Xiaobao, Jiang, Zhongxing, Gao, Li, Bai, Yuansong, Li, Yan, Xiong, Junye, Li, Runzi, Zou, Jianjun, Niu, Ting, Yang, Renchi, Hu, Yu

Cael y testun llawn Cael y testun llawn Cael y testun llawn